Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

Oncotarget | Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

News

November 8, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 2, 2022, entitled, “Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer.” continue reading »

Oncotarget | The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells

News

November 7, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on October 20, 2022, entitled, “The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells.” continue reading »

Oncotarget | Nectin-4 is widely expressed in head and neck squamous cell carcinoma

Oncotarget

November 3, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on October 20, 2022, entitled, “Nectin-4 is widely expressed in head and neck squamous cell carcinoma.” continue reading »

New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers

Oncotarget

November 2, 2022
Researchers published a research perspective about a recent study that uncovered FSP1 as a novel target gene that mediates ferroptosis resistance and radioresistance in lung cancer cells. continue reading »

Oncotarget is Again on MEDLINE

News

October 27, 2022
PRESS RELEASE: On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by MEDLINE/PubMed and PubMed Central/PubMed. continue reading »